Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The anti-influenza drug oseltamivir is an ester prodrug activated by hepatic carboxylesterases. Plasma esterases also convert up to 31.8% of the parent compound to the active metabolite after 4 h ex vivo, with wide interindividual variation. This source of error is removed by adding the esterase inhibitor dichlorvos to blood collection tubes.

Original publication

DOI

10.1128/AAC.00500-06

Type

Journal article

Journal

Antimicrob Agents Chemother

Publication Date

09/2006

Volume

50

Pages

3197 - 3199

Keywords

Adult, Antiviral Agents, Esterases, Female, Humans, Male, Organophosphates, Oseltamivir, Prodrugs